PKNOX1
gene geneOn this page
Also known as PREP1
Summary
PKNOX1 (PBX/knotted 1 homeobox 1, HGNC:9022) is a protein-coding gene on chromosome 21q22.3, encoding Homeobox protein PKNOX1 (P55347). Activates transcription in the presence of PBX1A and HOXA1.
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in angiogenesis. Predicted to act upstream of or within camera-type eye development; hemopoiesis; and positive regulation of transcription by RNA polymerase II. Located in cytosol and nucleus.
Source: NCBI Gene 5316 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 54 total
- Transcription factor: yes — 20 downstream targets (CollecTRI)
- MANE Select transcript:
NM_004571
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:9022 |
| Approved symbol | PKNOX1 |
| Name | PBX/knotted 1 homeobox 1 |
| Location | 21q22.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PREP1 |
| Ensembl gene | ENSG00000160199 |
| Ensembl biotype | protein_coding |
| OMIM | 602100 |
| Entrez | 5316 |
Gene structure
Transcript identifiers
Ensembl transcripts: 27 — 18 protein_coding, 6 retained_intron, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000291547, ENST00000418336, ENST00000432907, ENST00000456957, ENST00000474336, ENST00000480179, ENST00000557820, ENST00000558955, ENST00000560448, ENST00000607049, ENST00000607150, ENST00000883905, ENST00000883906, ENST00000883907, ENST00000883908, ENST00000883909, ENST00000883910, ENST00000883911, ENST00000883912, ENST00000911563, ENST00000911564, ENST00000911565, ENST00000911566, ENST00000911567, ENST00000911568, ENST00000963001, ENST00000963002
RefSeq mRNA: 3 — MANE Select: NM_004571
NM_001286258, NM_001320694, NM_004571
CCDS: CCDS13692, CCDS68211
Canonical transcript exons
ENST00000291547 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003491838 | 43004326 | 43004432 |
| ENSE00003513802 | 43010053 | 43010224 |
| ENSE00003520581 | 43021303 | 43021431 |
| ENSE00003551171 | 43016908 | 43017007 |
| ENSE00003572037 | 43029890 | 43033931 |
| ENSE00003597493 | 43018133 | 43018230 |
| ENSE00003627186 | 43007491 | 43007618 |
| ENSE00003699223 | 43024871 | 43024947 |
| ENSE00003700349 | 43028702 | 43028874 |
| ENSE00003738221 | 43013068 | 43013238 |
| ENSE00003889689 | 42974562 | 42974664 |
Expression profiles
Bgee: expression breadth ubiquitous, 273 present calls, max score 89.76.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.7104 / max 123.5973, expressed in 1796 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 189348 | 7.4800 | 1755 |
| 189349 | 1.9343 | 1112 |
| 189352 | 1.1153 | 538 |
| 189351 | 0.6547 | 354 |
| 189350 | 0.4699 | 277 |
| 189355 | 0.0379 | 6 |
| 189354 | 0.0125 | 5 |
| 189353 | 0.0057 | 3 |
Top tissues by expression
289 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 89.76 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 88.79 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.98 | gold quality |
| left testis | UBERON:0004533 | 87.93 | gold quality |
| thyroid gland | UBERON:0002046 | 87.92 | gold quality |
| testis | UBERON:0000473 | 87.80 | gold quality |
| right testis | UBERON:0004534 | 87.34 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 87.20 | gold quality |
| ganglionic eminence | UBERON:0004023 | 86.75 | gold quality |
| ventricular zone | UBERON:0003053 | 86.12 | gold quality |
| sural nerve | UBERON:0015488 | 86.11 | gold quality |
| cortical plate | UBERON:0005343 | 85.73 | gold quality |
| stromal cell of endometrium | CL:0002255 | 85.54 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 85.24 | gold quality |
| embryo | UBERON:0000922 | 84.97 | gold quality |
| endometrium | UBERON:0001295 | 84.27 | gold quality |
| blood | UBERON:0000178 | 84.08 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 83.11 | gold quality |
| calcaneal tendon | UBERON:0003701 | 83.00 | gold quality |
| cerebellum | UBERON:0002037 | 82.91 | gold quality |
| cerebellar cortex | UBERON:0002129 | 82.81 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 82.81 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 82.69 | gold quality |
| adrenal tissue | UBERON:0018303 | 82.67 | gold quality |
| sperm | CL:0000019 | 82.54 | gold quality |
| islet of Langerhans | UBERON:0000006 | 82.31 | gold quality |
| ovary | UBERON:0000992 | 82.09 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 82.08 | gold quality |
| left ovary | UBERON:0002119 | 82.00 | gold quality |
| entorhinal cortex | UBERON:0002728 | 81.97 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.44 |
| E-MTAB-7303 | no | 129.00 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
20 targets.
| Target | Regulation |
|---|---|
| ALDH1A2 | Unknown |
| BCL2L1 | Unknown |
| CCL2 | Activation |
| FABP7 | |
| FASN | Repression |
| GATA1 | Activation |
| HOXB1 | Unknown |
| HOXB2 | Unknown |
| IL10 | Activation |
| INPPL1 | Activation |
| MEIS1 | Unknown |
| NR5A1 | Unknown |
| PAX3 | Repression |
| PF4 | Unknown |
| PGK2 | |
| PTPN6 | Activation |
| REN | Unknown |
| RNF6 | Activation |
| SYP | Activation |
| UGT2B17 |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA0782.1 | PKNOX1 | TALE-type homeo domain factors |
| MA0782.2 | PKNOX1 | TALE-type homeo domain factors |
| MA0782.3 | PKNOX1 | TALE-type homeo domain factors |
JASPAR matrix evidence (PMIDs): PMID:25233378, PMID:23602564
Upstream regulators (CollecTRI, top): HOXA9
miRNA regulators (miRDB)
148 targeting PKNOX1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-223-3P | 99.99 | 70.14 | 1140 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
Literature-anchored findings (GeneRIF, showing 15)
- PREP1 regulates PF4 gene expression. (PMID:12732210)
- PKNOX1 gene-dosage imbalance is associated with overexpression of FABP7 in Down syndrome fetal brains. (PMID:12771203)
- PREP-1 has a role in F9 teratocarcinoma cells: it causes an increase of PBX-2 by preventing its degradation (PMID:12871956)
- Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1. (PMID:18093541)
- Immunohistochemistry on tissue micrroarrays (TMA) generated from three distinct human cohorts comprising a total of some 1000 human tumors revealed that 70% of the tumors express no or extremely low levels of Prep1, unlike normal tissues. (PMID:20106730)
- analysis of the regulatory region of the zebrafish Prep1.1 gene and the promoter of human PREP1 (PMID:21203543)
- The tumor suppressor role of Prep1 is associated with the maintenance of genomic stability. (PMID:21715654)
- High levels of MEIS1 and PREP1, and low levels of PBX4 expression were founded in samples of patients with ALL. (PMID:22185299)
- Single nucleotide polymorphism in gene encoding transcription factor Prep1 is associated with HIV-1-associated dementia (PMID:22347417)
- PREP1 modulates the cellular sensitivity to TGF-beta by inducing the small mothers against decapentaplegic homolog 3 (SMAD3) nuclear translocation. (PMID:25157139)
- the replication timing of a specific fraction of the human genome is affected by PREP1 tumor suppressor (PMID:29453404)
- These data implicate the upregulated hepatic expression of Pknox1 in type 2 diabetes mellitus (T2DM) complicated with nonalcoholic fatty liver disease (NAFLD) may be caused by the reduced expression of miR-17 family, indicating that developing miRNA-mediated regulation strategies on Pknox1 may provide new therapeutic options for metabolic disease (PMID:30338914)
- Mapping the native interaction surfaces of PREP1 with PBX1 by cross-linking mass-spectrometry and mutagenesis. (PMID:33033354)
- Polyunsaturated fatty acids ameliorate renal stone-induced renal tubular damage via miR-93-5p/Pknox1 axis. (PMID:36356379)
- PKNOX1 acts as a transcription factor of DHH and promotes the progression of stomach adenocarcinoma by regulating the Hedgehog signalling pathway. (PMID:37864517)
Cross-species orthologs
11 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | pknox1.1 | ENSDARG00000018765 |
| danio_rerio | pknox1.2 | ENSDARG00000036542 |
| mus_musculus | Pknox1 | ENSMUSG00000006705 |
| rattus_norvegicus | Pknox1 | ENSRNOG00000001184 |
| drosophila_melanogaster | exd | FBGN0000611 |
| drosophila_melanogaster | hth | FBGN0001235 |
| drosophila_melanogaster | vis | FBGN0033748 |
| drosophila_melanogaster | achi | FBGN0033749 |
| caenorhabditis_elegans | WBGENE00000443 | |
| caenorhabditis_elegans | WBGENE00006796 | |
| caenorhabditis_elegans | WBGENE00017690 |
Paralogs (13): MEIS3 (ENSG00000105419), PBX4 (ENSG00000105717), TGIF2 (ENSG00000118707), MEIS2 (ENSG00000134138), MEIS1 (ENSG00000143995), TGIF2LX (ENSG00000153779), PKNOX2 (ENSG00000165495), PBX3 (ENSG00000167081), TGIF2LY (ENSG00000176679), TGIF1 (ENSG00000177426), PBX1 (ENSG00000185630), MEIS3P2 (ENSG00000188013), PBX2 (ENSG00000204304)
Protein
Protein identifiers
Homeobox protein PKNOX1 — P55347 (reviewed: P55347)
Alternative names: Homeobox protein PREP-1, PBX/knotted homeobox 1
All UniProt accessions (4): P55347, E7EPN6, H0YM69, Q96I87
UniProt curated annotations — full annotation on UniProt →
Function. Activates transcription in the presence of PBX1A and HOXA1.
Subunit / interactions. Interacts with MN1.
Subcellular location. Nucleus.
Tissue specificity. Ubiquitous. Isoform 2 is expressed in all examined tissues except in bone marrow.
Similarity. Belongs to the TALE/MEIS homeobox family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P55347-1 | 1 | yes |
| P55347-2 | 2, PKNOX1B |
RefSeq proteins (3): NP_001273187, NP_001307623, NP_004562* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR008422 | KN_HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR032453 | PKNOX/Meis_N | Domain |
| IPR050224 | TALE_homeobox | Family |
Pfam: PF05920, PF16493
UniProt features (20 total): sequence variant 3, sequence conflict 3, helix 3, region of interest 2, compositionally biased region 2, modified residue 2, chain 1, domain 1, turn 1, DNA-binding region 1, splice variant 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 1X2N | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P55347-F1 | 61.97 | 0.25 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 33, 41
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogenesis |
MSigDB gene sets: 198 (showing top):
GOBP_MYELOID_CELL_DIFFERENTIATION, MULLIGHAN_NPM1_SIGNATURE_3_UP, BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3, DORSAM_HOXA9_TARGETS_UP, GOBP_MYELOID_CELL_HOMEOSTASIS, TGCACTT_MIR519C_MIR519B_MIR519A, GOBP_ERYTHROCYTE_HOMEOSTASIS, TATTATA_MIR374, WEI_MYCN_TARGETS_WITH_E_BOX, MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN, RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP, FISCHER_G2_M_CELL_CYCLE, RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN, GOBP_BLOOD_VESSEL_MORPHOGENESIS, SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN
GO Biological Process (9): angiogenesis (GO:0001525), transcription by RNA polymerase II (GO:0006366), T cell differentiation (GO:0030217), erythrocyte differentiation (GO:0030218), camera-type eye development (GO:0043010), positive regulation of transcription by RNA polymerase II (GO:0045944), regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357), hemopoiesis (GO:0030097)
GO Molecular Function (8): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), chromatin binding (GO:0003682), DNA-binding transcription factor activity (GO:0003700), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515), sequence-specific DNA binding (GO:0043565)
GO Cellular Component (5): chromatin (GO:0000785), nucleus (GO:0005634), transcription regulator complex (GO:0005667), cytoplasm (GO:0005737), cytosol (GO:0005829)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Activation of HOX genes during differentiation | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| DNA-templated transcription | 2 |
| regulation of transcription by RNA polymerase II | 2 |
| transcription by RNA polymerase II | 2 |
| regulation of DNA-templated transcription | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| binding | 2 |
| blood vessel morphogenesis | 1 |
| anatomical structure formation involved in morphogenesis | 1 |
| lymphocyte differentiation | 1 |
| T cell activation | 1 |
| myeloid cell differentiation | 1 |
| erythrocyte homeostasis | 1 |
| eye development | 1 |
| positive regulation of DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cell development | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| DNA binding | 1 |
| chromosome | 1 |
| intracellular membrane-bounded organelle | 1 |
| protein-containing complex | 1 |
| intracellular anatomical structure | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
1572 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PKNOX1 | PBX1 | P40424 | 988 |
| PKNOX1 | PBX2 | P40425 | 808 |
| PKNOX1 | HOXB1 | P14653 | 772 |
| PKNOX1 | HOXB2 | P10913 | 721 |
| PKNOX1 | WDR4 | P57081 | 674 |
| PKNOX1 | PTTG1IP | P53801 | 641 |
| PKNOX1 | NDUFV3 | P56181 | 634 |
| PKNOX1 | PAX6 | P26367 | 613 |
| PKNOX1 | JAM2 | P57087 | 589 |
| PKNOX1 | H7C2H4 | H7C2H4 | 570 |
| PKNOX1 | P0DN79 | P0DN79 | 569 |
| PKNOX1 | U2AF1 | Q01081 | 559 |
| PKNOX1 | SYNJ1 | O43426 | 544 |
| PKNOX1 | DYRK1A | Q13627 | 526 |
| PKNOX1 | UBR1 | Q8IWV7 | 517 |
IntAct
121 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PBX1 | PKNOX1 | psi-mi:“MI:0915”(physical association) | 0.810 |
| PKNOX1 | PBX1 | psi-mi:“MI:0915”(physical association) | 0.810 |
| PKNOX1 | PBX2 | psi-mi:“MI:0915”(physical association) | 0.740 |
| PBX2 | PKNOX1 | psi-mi:“MI:0915”(physical association) | 0.740 |
| PKNOX1 | NUP58 | psi-mi:“MI:0915”(physical association) | 0.720 |
| NUP58 | PKNOX1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| VPS37C | PKNOX1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| HMGB2 | PKNOX1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| PKNOX1 | PBX4 | psi-mi:“MI:0915”(physical association) | 0.670 |
| PKNOX1 | FHL2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| CCDC120 | AIP | psi-mi:“MI:0914”(association) | 0.640 |
| PKNOX1 | BORCS6 | psi-mi:“MI:0915”(physical association) | 0.600 |
| PKNOX1 | EGD1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EGD1 | PKNOX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (97): PKNOX1 (Two-hybrid), VPS37C (Two-hybrid), PKNOX1 (Affinity Capture-RNA), VPS33A (Affinity Capture-MS), PBX1 (Affinity Capture-MS), PBX2 (Affinity Capture-MS), PBX4 (Affinity Capture-MS), VPS16 (Affinity Capture-MS), SAR1B (Affinity Capture-MS), PKNOX1 (Affinity Capture-Western), PBX1 (Affinity Capture-Western), PBX4 (Affinity Capture-MS), PBX1 (Affinity Capture-MS), PBX2 (Affinity Capture-MS), PKNOX1 (Affinity Capture-MS)
ESM2 similar proteins: A0A1L8H0H2, A0JN51, A4QNP0, F8VPJ6, O13186, O46567, O57415, O70477, O94842, P09775, P15257, P22361, P28324, P32519, P36197, P37275, P50534, P55347, P59759, P79686, Q05041, Q07243, Q0P5K4, Q14872, Q15723, Q2HJ84, Q2KHR2, Q3UH06, Q5R6A9, Q5W1J6, Q60542, Q60775, Q61321, Q62947, Q64318, Q6DJL0, Q6IRR0, Q6XLJ0, Q86T24, Q8AYC1
Diamond homologs: A1YGI6, A6NDR6, A8K0S8, A8WL06, B7ZRT8, O00470, O04136, O14770, O22300, O42261, O46339, O65685, O70477, P41779, P41817, P46606, P48000, P48001, P48002, P48731, P53147, P54269, P55347, P56659, P56660, P56664, P56665, P56669, P70284, P78412, P78413, P78414, P78415, P79937, P81067, P81068, P97367, P97368, Q0E3C3, Q0J6N4
SIGNOR signaling
5 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| PKNOX1 | “up-regulates activity” | HOXA1 | binding |
| PKNOX1 | “up-regulates quantity by expression” | SYP | “transcriptional regulation” |
| PKNOX1 | “up-regulates quantity by expression” | PTPN6 | “transcriptional regulation” |
| PKNOX1 | “up-regulates activity” | PBX1 | binding |
| PKNOX1 | “up-regulates activity” | HOXB1 | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 65 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| eye development | 6 | 35.7× | 5e-06 |
| animal organ morphogenesis | 7 | 22.7× | 5e-06 |
| brain development | 7 | 9.4× | 1e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
54 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 38 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1759 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:42974664:GGTA:G | donor_loss | 1.0000 |
| 21:42974666:T:A | donor_loss | 1.0000 |
| 21:43004321:TCCA:T | acceptor_loss | 1.0000 |
| 21:43004322:CCA:C | acceptor_loss | 1.0000 |
| 21:43004323:CA:C | acceptor_loss | 1.0000 |
| 21:43004324:A:AC | acceptor_loss | 1.0000 |
| 21:43004324:A:AG | acceptor_gain | 1.0000 |
| 21:43004325:G:GG | acceptor_gain | 1.0000 |
| 21:43004325:GA:G | acceptor_gain | 1.0000 |
| 21:43004325:GAC:G | acceptor_gain | 1.0000 |
| 21:43004325:GACA:G | acceptor_gain | 1.0000 |
| 21:43004325:GACAC:G | acceptor_gain | 1.0000 |
| 21:43004428:AACAG:A | donor_loss | 1.0000 |
| 21:43004429:ACAGG:A | donor_loss | 1.0000 |
| 21:43004433:G:GA | donor_loss | 1.0000 |
| 21:43004434:T:A | donor_loss | 1.0000 |
| 21:43007487:ACAG:A | acceptor_loss | 1.0000 |
| 21:43007488:CA:C | acceptor_loss | 1.0000 |
| 21:43007489:A:AC | acceptor_loss | 1.0000 |
| 21:43007489:A:AG | acceptor_gain | 1.0000 |
| 21:43007489:AGAT:A | acceptor_gain | 1.0000 |
| 21:43007490:G:GA | acceptor_gain | 1.0000 |
| 21:43007490:GATG:G | acceptor_gain | 1.0000 |
| 21:43007490:GATGC:G | acceptor_gain | 1.0000 |
| 21:43010048:CTCA:C | acceptor_loss | 1.0000 |
| 21:43010050:CA:C | acceptor_loss | 1.0000 |
| 21:43010051:A:AC | acceptor_loss | 1.0000 |
| 21:43010051:A:AG | acceptor_gain | 1.0000 |
| 21:43010052:G:GC | acceptor_loss | 1.0000 |
| 21:43010052:G:GG | acceptor_gain | 1.0000 |
AlphaMissense
2877 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 21:43010061:T:C | L63P | 1.000 |
| 21:43010093:T:C | C74R | 1.000 |
| 21:43010095:T:G | C74W | 1.000 |
| 21:43013077:G:C | A121P | 1.000 |
| 21:43013090:T:C | L125S | 1.000 |
| 21:43013093:G:C | R126P | 1.000 |
| 21:43013096:T:C | I127T | 1.000 |
| 21:43013096:T:G | I127S | 1.000 |
| 21:43013098:C:G | H128D | 1.000 |
| 21:43013099:A:G | H128R | 1.000 |
| 21:43013100:T:A | H128Q | 1.000 |
| 21:43013100:T:G | H128Q | 1.000 |
| 21:43013102:T:C | L129P | 1.000 |
| 21:43013105:T:C | L130P | 1.000 |
| 21:43013107:G:A | E131K | 1.000 |
| 21:43013108:A:T | E131V | 1.000 |
| 21:43013109:G:C | E131D | 1.000 |
| 21:43013109:G:T | E131D | 1.000 |
| 21:43013111:T:C | L132P | 1.000 |
| 21:43013129:T:A | L138H | 1.000 |
| 21:43013129:T:C | L138P | 1.000 |
| 21:43013132:G:A | C139Y | 1.000 |
| 21:43013133:C:G | C139W | 1.000 |
| 21:43013140:T:A | F142I | 1.000 |
| 21:43013140:T:C | F142L | 1.000 |
| 21:43013141:T:C | F142S | 1.000 |
| 21:43013141:T:G | F142C | 1.000 |
| 21:43013142:C:A | F142L | 1.000 |
| 21:43013142:C:G | F142L | 1.000 |
| 21:43013145:C:G | C143W | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000082680 (21:43005178 C>A,T), RS1000170550 (21:42982547 T>C,G), RS1000191057 (21:42980829 T>A,C), RS1000311611 (21:42988752 T>C), RS1000331560 (21:43017064 G>A,T), RS1000344515 (21:42977803 T>C), RS1000349769 (21:43011128 T>C), RS1000464208 (21:43021668 C>T), RS1000474673 (21:43005298 T>A), RS1000556048 (21:43015590 A>G), RS1000574293 (21:42992469 A>G), RS1000581486 (21:42998456 A>G), RS1000604011 (21:42981482 G>T), RS1000630780 (21:42987163 C>T), RS1000673911 (21:42973130 C>T)
Disease associations
OMIM: gene MIM:602100 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000328_10 | Biochemical measures | 8.000000e-06 |
| GCST000328_8 | Biochemical measures | 8.000000e-06 |
| GCST000579_6 | Cognitive performance | 2.000000e-07 |
| GCST000905_11 | Information processing speed | 6.000000e-06 |
| GCST002670_11 | Blood and toenail selenium levels | 3.000000e-08 |
| GCST002670_12 | Blood and toenail selenium levels | 5.000000e-09 |
| GCST002670_4 | Blood and toenail selenium levels | 4.000000e-09 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004611 | low density lipoprotein cholesterol measurement |
| EFO:0004574 | total cholesterol measurement |
| EFO:0003926 | neuropsychological test |
| EFO:0004363 | information processing speed |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs2839629 | PKNOX1 | 0.00 | 0 |
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| FR900359 | increases phosphorylation | 1 |
| bisphenol A | decreases methylation | 1 |
| sodium arsenite | increases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| PCI 5002 | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Arsenic Trioxide | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Ethyl Methanesulfonate | decreases expression | 1 |
| Phthalic Acids | increases methylation | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Zinc | affects cotreatment, increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| beta-Naphthoflavone | increases expression | 1 |
| Acrylamide | increases expression | 1 |
| Particulate Matter | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_E2GU | HAP1 PKNOX1 (-) | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.